9-10-epoxy-12-octadecenoate and Neuralgia

9-10-epoxy-12-octadecenoate has been researched along with Neuralgia* in 1 studies

Other Studies

1 other study(ies) available for 9-10-epoxy-12-octadecenoate and Neuralgia

Article	Year
Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain. Proceedings of the National Academy of Sciences of the United States of America, 2016, 11-01, Volume: 113, Issue:44 Chemotherapy-induced peripheral neuropathic pain (CIPNP) is a severe dose- and therapy-limiting side effect of widely used cytostatics that is particularly difficult to treat. Here, we report increased expression of the cytochrome-P Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antineoplastic Agents, Phytogenic; Benzimidazoles; Benzoates; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Female; Ganglia, Spinal; Gene Expression Regulation, Enzymologic; HEK293 Cells; Humans; Linoleic Acids; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; Neuralgia; Paclitaxel; Pain Threshold; Telmisartan	2016

Article

Year

Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain.

Proceedings of the National Academy of Sciences of the United States of America, 2016, 11-01, Volume: 113, Issue:44

Chemotherapy-induced peripheral neuropathic pain (CIPNP) is a severe dose- and therapy-limiting side effect of widely used cytostatics that is particularly difficult to treat. Here, we report increased expression of the cytochrome-P

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antineoplastic Agents, Phytogenic; Benzimidazoles; Benzoates; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Female; Ganglia, Spinal; Gene Expression Regulation, Enzymologic; HEK293 Cells; Humans; Linoleic Acids; Male; Mice, Inbred C57BL; Molecular Targeted Therapy; Neuralgia; Paclitaxel; Pain Threshold; Telmisartan

2016